3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Medulloblastoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Neuroectodermal Tumors, Primitive
1
Neuroectodermal Tumors
1
Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Temozolomide
2
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Sunitinib
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Maintenance Chemotherapy
1
Lutetium-177
1
Lutetium
1
Lomustine
1
Interleukin-12
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Erlotinib Hydrochloride
1
Cisplatin
1
Busulfan
1
Bone Marrow Transplantation
1
Aminolevulinic Acid
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroectodermal Tumors
×
Maintenance Chemotherapy
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled